ArticleRheumatology and therapy2026

Safety and Effectiveness of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan: A Post-Marketing Surveillance Study.

Fumio Akita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.